Hedysarimcoumestan?B

CAS No. 899436-04-5

Hedysarimcoumestan?B( ——— )

Catalog No. M38175 CAS No. 899436-04-5

Hedysarimcoumestan B is a natural product that can be isolated from the roots of Hedysarum multijugum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Hedysarimcoumestan?B
  • Note
    Research use only, not for human use.
  • Brief Description
    Hedysarimcoumestan B is a natural product that can be isolated from the roots of Hedysarum multijugum.
  • Description
    Hedysarimcoumestan B is a natural product that can be isolated from the roots of Hedysarum multijugum.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    899436-04-5
  • Formula Weight
    298.25
  • Molecular Formula
    C16H10O6
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wang W, et al. Coumestans from Hedysarum multijugum. J Nat Prod. 2006 Jun;69(6):876-80.?
molnova catalog
related products
  • HIF-1 alpha (556-574...

    This is a hypoxia-inducible factor-1 (HIF-1 a) 19-mer fragment. HIF-1 functions as master regulator of response to oxygen homeostasis. Hypoxia-induced gene expression is initiated when HIF-1 subunit is stabilized in response to a lack of oxygen. This part of HIF-1 binds to the von Hippel-Lindau factor (VHL) an E3 ubiquitin ligase, and the proline 564 is absolutely critical to the binding process.

  • NOT Receptor Modulat...

    NOT Receptor Modulator 1 is a modulator of nuclear receptor NOT.

  • BLU2864

    BLU2864 is an orally active, highly selective, ATP-competitive PRKACA inhibitor with an IC50 of 0.3 nM, exhibiting anti-tumor activity and potential applications in cancer and polycystic kidney disease research .